Jessica Stolzenberger Boehringer Ingelheim Pharma GmbH & Co. KG
![Jessica Stolzenberger Jessica Stolzenberger](https://pda.org/images/default-source/speaker-photos/jessica-stolzenberger-1980916.jpeg.jpeg?sfvrsn=95325fe4_1)
Jessica Stolzenberger Boehringer Ingelheim Pharma GmbH & Co. KG Associate Director Late Stage Downstream Development
Jessica Stolzenberger is leading a Late Stage Downstream laboratory at Boehringer Ingelheim, Germany, with more than 20 years of experience in Downstream process development for commercial facilities. For the past 6 years, she starts developing the impact of Endotoxin removal during downstream processing. She published the first endotoxin removal study by considering the impact of endotoxin masking.